Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

66.38
-0.9100-1.35%
Post-market: 67.080.7000+1.05%18:46 EDT
Volume:2.44M
Turnover:161.97M
Market Cap:8.65B
PE:-112.82
High:67.70
Open:65.17
Low:64.03
Close:67.29
52wk High:67.70
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:1.07
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:10.48
PE(LYR):-190.17

Loading ...

10x Genomics to join BofA Securities Healthcare Conference fireside chat

Reuters
·
Apr 30

Is Atera’s New Spatial Biology Platform Altering The Investment Case For 10x Genomics (TXG)?

Simply Wall St.
·
Apr 22

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Brookdale Senior Living (BKD) and 10x Genomics (TXG)

TIPRANKS
·
Apr 21

10x Genomics Is Maintained at Neutral by B of A Securities

Dow Jones
·
Apr 20

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Arrowhead Pharmaceuticals (ARWR) and Legend Biotech (LEGN)

TIPRANKS
·
Apr 20

10x Genomics, Inc. : Bofa Global Research Raises Price Objective to $30.00 From $21.00

THOMSON REUTERS
·
Apr 20

U.S. RESEARCH ROUNDUP-Carpenter Technology, IBM, Ulta Beauty

Reuters
·
Apr 20

10x Genomics announces Atera, a new in situ spatial biology platform

TIPRANKS
·
Apr 20

10x Genomics publishes Atera presentation outlining new high-throughput spatial transcriptomics platform

Reuters
·
Apr 19

10x Genomics CEO Serge Saxonov disposes 5,000 shares for $122,784

Reuters
·
Apr 17

10x Genomics to report first-quarter financial results after market close

Reuters
·
Apr 16

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
Apr 15

10x Genomics Is Maintained at Neutral by Citigroup

Dow Jones
·
Apr 08

10x Genomics Inc : Citigroup Raises Target Price to $24 From $18

THOMSON REUTERS
·
Apr 07

10x Genomics price target raised to $24 from $18 at Citi

TIPRANKS
·
Apr 07

U.S. RESEARCH ROUNDUP-Centerspace, Union Pacific, XPO

Reuters
·
Apr 07

10x Genomics Shares Rise After William Blair Upgrade

MT Newswires Live
·
Apr 01

William Blair Upgrades 10x Genomics to Outperform From Market Perform

MT Newswires Live
·
Mar 31

10x Genomics upgraded to Outperform from Market Perform at William Blair

TIPRANKS
·
Mar 31

10x Genomics; CEO Serge Saxonov reports common stock disposal valued at $287,000

Reuters
·
Mar 26